An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

NCT01571596 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Hypophosphatemia

Interventions

DRUG: KRN23

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]